Loading...
Metabolic & Weight Management
Semaglutide
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes management. It has demonstrated significant efficacy for weight management by reducing appetite, slowing gastric emptying, and improving glycemic control.
Available Delivery Methods
SubQ InjectionOral Capsule
Why Semaglutide
Key Benefits
- Clinically proven to support significant weight loss
- Reduces appetite and food cravings
- Improves glycemic control and insulin sensitivity
- Supports cardiovascular health markers
- Once-weekly dosing for sustained results
The Science
How It Works
Semaglutide mimics endogenous GLP-1, binding to GLP-1 receptors in the pancreas, gut, and brain. It stimulates insulin secretion, suppresses glucagon release, slows gastric emptying, and acts on hypothalamic appetite centers to reduce hunger and promote satiety.
Safety & Side Effects
Common side effects include nausea, vomiting, and diarrhea, which typically improve as the body adjusts during dose titration. Semaglutide should not be used in patients with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
Metabolic & Weight Management
Related Therapies
Interested in Semaglutide?
Speak with a licensed clinician to find out if Semaglutide is right for your protocol.
Book a Consultation